CD14 and cancer: Furthermore, in the vast majority of solid cancer models, M2-like Mφs and/or TAMs at the cancer site differentiate in situ from circulating CCR2+CD14++CD16– classical monocytes (Table 1), recruited via cancer cell-secreted CCL2 (Qian et al., 2011; Cassetta et al., 2019).